JS

Jayne Shaw

BCAL Diagnostics Limited | Executive Chairman, Executive Director
Ms Shaw is Trained as a Registered Nurse in the UK, on arrival in Australia Jayne became a Director of Nursing and Chief Executive Officer of two private hospitals. Following this, she established an Australian and international consulting business which was sold to Healthsouth a US Healthcare company. Ms Shaw has been a member of a number of private healthcare boards involved with specialist consolidation including cardiology, orthopaedics, and women's health, and continued to work with private equity firms on local and International Healthcare transactions.

Companies and Roles

Company
Title
Tenure
Since
BDX
BDX
BCAL Diagnostics Limited
  • Executive Chairman
  • Executive Director
14yrs, 4mthFeb 2010
COO
COO
Corum Group Limited
  • Non-Executive Director
3yrs, 8mthOct 2020
PHX
PHX
PharmX Technologies Limited
  • Non-Executive Director
3yrs, 8mthOct 2020

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
BDX
BDX
BCAL Diagnostics Limited
14/06/24N/A31,584,4180N/A
PHX
PHX
PharmX Technologies Limited
23/08/23N/A2,780,953N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
BDX
BDX
BCAL Diagnostics Limited
14/06/24
Buy
725,000$0.106$76,999On-market trade
BDX
BDX
BCAL Diagnostics Limited
23/11/23
Exercise
2,022,638$0.057$116,099Exercise of options
BDX
BDX
BCAL Diagnostics Limited
23/11/23
Buy
2,022,638$0.057$116,099Exercise of options
BDX
BDX
BCAL Diagnostics Limited
18/09/23
Buy
300,000$0.100$30,000Participation in share purchase plan
BDX
BDX
BCAL Diagnostics Limited
01/07/22
Buy
410,035$0.076$30,966On-market trade